Amanta Healthcare, an Ahmedabad-based pharmaceutical company, is set to debut on the market with modest expectations, indicated by a GMP of 7%. The IPO, which closed on September 3rd, saw the company issue fresh shares to fund expansion, including a new SteriPort manufacturing line.
Why FIIs are dumping bluechips to hunt small & midcaps
Foreign institutional investors are shifting their focus from India’s top blue-chip stocks to a wider array of mid- and small-cap companies. This strategic repositioning is